TractionWandercraft has expanded globally, launched pivotal clinical trials, and received FDA clearance for the Atalante X exoskeleton. The company has also entered a strategic partnership with Renault Group.Organizations InvolvedRenault GroupFoundersMatthieu MasselinMarketRehabilitation and Mobility SolutionsLocationFranceCoinvestorsRenault Group, PSIM fund, Teampact Ventures, Quadrant Management Company Description
Wandercraft is a company that develops AI-powered robotic exoskeletons, including the Atalante X rehabilitation system and the upcoming Eve personal exoskeleton. The company aims to transform mobility and rehabilitation for individuals with limited mobility.